We read with interest the Correspondence by Zhiqi Yao and colleagues1 published in The Lancet Diabetes & Endocrinology, which ...

Prediabetes is an important clinical concern. Not only is it a harbinger of future type 2 diabetes—with all the attendant ...

Neutralising monoclonal antibodies (NAbs) are being developed for future respiratory virus threats, notably highly pathogenic ...

Despite significant advances in early detection, surgery, radiotherapy, and systemic treatment of breast cancer, late relapse ...

Professor Sir Tumani Corrah is the Emeritus Director of the Medical Research Council (MRC) Unit The Gambia at the London ...

Countries have a legal obligation to combat climate change. The challenge for health is to make sure that they comply. Udani ...

On July 17, 2025, the US Food and Drug Administration (FDA) authorised marketing of five Juul e-cigarette products to adults, ...

Overtreatment is considered harmful in terms of decreasing quality of life, wasting resources, and environmental damage.1–3 ...

Human monoclonal antibodies targeting rabies glycoprotein have been proposed as a potential alternative to rabies immunoglobulin to neutralise rabies virus at the wound site until sufficient virus ...

The Lancet Commission on Gender and Global Health lucidly highlighted how attacks on the concept of gender, and on gender equality and women's rights more broadly, are not new. As Sarah Hawkes and her ...

As of July 23, 2025, Israel's military assault on Gaza has killed over 59 219 Palestinians, wounded an additional 143 045, and displaced nearly all of the 2·1 million people who live there.1 ...

In September, 2025, global stakeholders will convene at the United Nations General Assembly for the fourth High-Level Meeting ...